Jingbo Yu

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Topics

Cross Sectional

Allogeneic Hematopoietic Stem Cell Transplantation

Ejection Fraction

Top Venues

Oncology and therapy

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Betty K Hamilton, Paul Williams, John Galvin, James Turnbull, Jingbo Yu
Disability Associated with Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation: Analysis of a Cross-Sectional US Patient Survey. Oncology and therapy (2024)
Michael Richard Grunwald, Ellen K Ritchie, Elisa Rumi, Albert Assad, J E Hamer-Maansson, Jingbo Yu, Tricia Kalafut, Evan Braunstein, Francesco Passamonti
Treatment comparison of hydroxyurea versus ruxolitinib in essential thrombocythaemia: A matched-cohort analysis. EJHaem 5 (4) (2024)
Aaron T Gerds, Ruben Mesa, John M Burke, Michael R Grunwald, Brady L Stein, Peg Squier, Jingbo Yu, J E Hamer-Maansson, Stephen T Oh
Association between elevated white blood cell counts and thrombotic events in polycythemia vera: analysis from REVEAL. Blood 143 (16) (2024)
Michael Richard Grunwald, Ellen K Ritchie, Elisa Rumi, Albert Assad, J E Hamer-Maansson, Jingbo Yu, Tricia Kalafut, Evan Braunstein, Francesco Passamonti
Treatment comparison of hydroxyurea versus ruxolitinib in essential thrombocythaemia: A matched-cohort analysis. EJHaem 5 (4) (2024)
Jingbo Yu, James Nelson, Taylor Marlin, Evan Braunstein, Michelle Jerry
Direct and indirect costs for patients with myeloproliferative neoplasms. Leukemia & lymphoma (2024)
Aaron T Gerds, Ruben Mesa, John M Burke, Michael R Grunwald, Brady L Stein, Peg Squier, Jingbo Yu, J E Hamer-Maansson, Stephen T Oh
Association between elevated white blood cell counts and thrombotic events in polycythemia vera: analysis from REVEAL. Blood 143 (16) (2024)
Betty K Hamilton, Paul Williams, John Galvin, James Turnbull, Jingbo Yu
Disability Associated with Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation: Analysis of a Cross-Sectional US Patient Survey. Oncology and therapy 12 (3) (2024)
Betty K Hamilton, Paul Williams, John Galvin, James Turnbull, Jingbo Yu
Disability Associated with Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation: Analysis of a Cross-Sectional US Patient Survey. Oncology and therapy 12 (3) (2024)
Jingbo Yu, James Nelson, Taylor Marlin, Evan Braunstein, Michelle Jerry
Direct and indirect costs for patients with myeloproliferative neoplasms. Leukemia & lymphoma 65 (8) (2024)
Betty K Hamilton, Paul Williams, John Galvin, James Turnbull, Jingbo Yu
Disability Associated with Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation: Analysis of a Cross-Sectional US Patient Survey. Oncology and therapy 12 (3) (2024)
Aaron T Gerds, Ruben A Mesa, John M Burke, Michael R Grunwald, Brady L Stein, Peg Squier, Jingbo Yu, J E Hamer-Maansson, Stephen T Oh
Association between elevated white blood cell counts and thrombotic events in polycythemia vera: Analysis from REVEAL. Blood (2023)
Aaron T Gerds, Jingbo Yu, Anne Shah, Ann Xi, Shambhavi Kumar, Robyn M Scherber, Shreekant Parasuraman
Ruxolitinib for myelofibrosis in elderly non-transplant patients: healthcare resource utilization and costs. Journal of medical economics (2023)
Aaron T Gerds, Ruben A Mesa, John M Burke, Michael R Grunwald, Brady L Stein, Peg Squier, Jingbo Yu, J E Hamer-Maansson, Stephen T Oh
Association between elevated white blood cell counts and thrombotic events in polycythemia vera: Analysis from REVEAL. Blood (2023)
Jingbo Yu, Dilan Paranagama, Shreekant Parasuraman
Recruitment strategies and geographic representativeness for patient survey studies in rare diseases: Experience from the living with myeloproliferative neoplasms patient survey. PloS one 15 (12) (2020)